Kainos Group - KNOS Share Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kainos Group in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" KNOS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KNOS, but not buy additional shares or sell existing shares.
View KNOS analyst ratings or view top-rated stocks.

3 analysts have issued twelve-month price targets for Kainos Group's shares. Their KNOS share price forecasts range from GBX 1,200 to GBX 1,400. On average, they anticipate the company's share price to reach GBX 1,300 in the next twelve months. This suggests that the stock has a possible downside of 11.3%.
View analysts price targets for KNOS or view top-rated stocks among Wall Street analysts.

Kainos Group's stock was trading at GBX 1,917 at the beginning of 2022. Since then, KNOS shares have decreased by 23.5% and is now trading at GBX 1,465.85.
View the best growth stocks for 2022 here.

Kainos Group declared a dividend on Monday, May 23rd. Stockholders of record on Thursday, October 6th will be given a dividend of GBX 15.10 per share on Friday, October 28th. This represents a yield of 1.46%. The ex-dividend date of this dividend is Thursday, October 6th. This is a positive change from the stock's previous dividend of GBX 7.10. The official announcement can be seen at this link.
Read our dividend analysis for KNOS.

Kainos Group (LON:KNOS) pays an annual dividend of GBX 0.22 per share and currently has a dividend yield of 1.52%. The dividend payout ratio is 79.29%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for KNOS.

Based on aggregate information from My MarketBeat watchlists, some companies that other Kainos Group investors own include GW Pharmaceuticals (GWPH), NetApp (NTAP), Twitter (TWTR), Vuzix (VUZI), Arbutus Biopharma (ABUS), Heat Biologics (HTBX), Lloyds Banking Group (LYG), Marvell Technology (MRVL), McEwen Mining (MUX) and Nokia Oyj (NOK).

Kainos Group trades on the London Stock Exchange (LON) under the ticker symbol "KNOS."

Shares of KNOS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of KNOS stock can currently be purchased for approximately GBX 1,465.85.

Kainos Group (LON:KNOS) has a market capitalization of £1.82 billion and generates £302.63 million in revenue each year.

The company employs 2,121 workers across the globe.

Kainos Group's mailing address is 4-6 Upper Crescent, BELFAST, NIR BT7 1NT, United Kingdom. The official website for the company is www.kainos.com. The company can be reached via phone at +44-28-90571100.